Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise

Courtney.Jones.jpg

Cancer stem cells get energy from protein, and it’s proving to be their Achilles’ heel

CU Cancer Center study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Turning off protein metabolism kills these cells.
12-Nov-2018 11:05 AM EST Add to Favorites

light.switch.jpg

New combination treatment flips the switch on melanoma cells

Navitoclax plus A-1210477 not only killed melanoma cells, but also killed the melanoma initiating cells (aka cancer stem cells) that often resist therapy.
23-Oct-2018 12:05 PM EDT Add to Favorites

Mayumi.Fujita.2.jpg

Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."
12-Oct-2018 8:05 AM EDT Add to Favorites

News.Craig.Jordan.jpg

Cancer Hijacks the Microbiome to Glut Itself on Glucose

A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth.
28-Sep-2018 11:05 AM EDT Add to Favorites

Ross.Camidge.2018.Web.II.jpg

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

Results of ALTA-1 trial: Patients given brigatinib saw a statistically significant 51 percent reduction in the risk of progression or death compared with those given crizotinib.
25-Sep-2018 8:05 AM EDT Add to Favorites

Bob.Doebele.2018.iv.jpg

Promising Phase 1/2 Results for Entrectinib Against ROS1+ Non-Small Cell Lung Cancer

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on...
24-Sep-2018 8:45 AM EDT Add to Favorites

News.Craig.Jordan.jpg

New Combination Treatment Targets Pre-Leukemia Stem Cells

Omacetaxine (to block protein synthesis) with venetoclax (to block oxidative phosphorylation), was highly effective against CD123+ leukemia stem cells.
12-Sep-2018 1:05 PM EDT Add to Favorites

Shark.jpg

Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.
17-Aug-2018 12:15 PM EDT Add to Favorites


see all news

Our Experts on Newswise

Neil.Box.jpg.JPG

Will One Bad Sunburn Give You Skin Cancer?

27-Jul-2015 11:05 AM EDT

Aisner_Dara_2010.jpg

Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing

An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

The mission of the University of Colorado Cancer Center is to discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.

Contacts

Erika Matich
Communications Manager

303-724-0114

Garth Sundem
Science Writer
Cancer Science

303-724-6441

Twitter

Chat now!